home / stock / roch / roch news


ROCH News and Press, Roth CH Acquisition I Co.

Stock Information

Company Name: Roth CH Acquisition I Co.
Stock Symbol: ROCH
Market: NASDAQ
Website: rothch.com

Menu

ROCH ROCH Quote ROCH Short ROCH News ROCH Articles ROCH Message Board
Get ROCH Alerts

News, Short Squeeze, Breakout and More Instantly...

ROCH - Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff

2026-02-11 10:00:00 ET It takes all the running you can do to keep in the same place. If you want to get somewhere else, you must run at least twice as fast! —Through the Looking-Glass (Lewis Carroll) Looking Back About 1.5 years ago, I opened a Long p...

ROCH - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

2026-01-29 22:30:00 ET The following segment was excerpted from the Harbor Small Cap Growth Fund ( HASGX ) Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

ROCH - Roche Holding AG (RHHBY) Q4 2025 Earnings Call Transcript

2026-01-29 20:23:15 ET Roche Holding AG (RHHBY) Q4 2025 Earnings Call January 29, 2026 7:30 AM EST Company Participants Thomas Schinecker - Group Chief Executive Officer Alan Hippe - Chief Financial Officer Teresa Graham - Chief Executive Officer of Roche Pharmaceu...

ROCH - Roche Holding Non-GAAP EPS of CHF 19.46, revenue of CHF 61.52B; issues FY26 outlook

2026-01-29 01:37:52 ET More on Roche Holding Roche's CT-388 Adds Optionality In The GLP Market, But Wait For Dips Roche Is The 'Value Play' Of The 2026 Obesity Gold Rush Roche: Important De-Risking Of CT-388 In Obesity, Petrelintide Is Next Genentech sees str...

ROCH - Guardant Health: Look For Explosive Revenue Growth Ahead

2026-01-26 09:31:41 ET Guardant Health, Inc. ( GH ) was founded in 2012 and is based in Palo Alto, CA. It describes itself as a "precision oncology company focused on guarding wellness and giving every person more time free from cancer." The company operates in the field of oncology...

ROCH - RAPT Therapeutics: A Buy As GSK Acquisition Highlights Long-Acting IgE Candidate

2026-01-20 15:15:45 ET The last time I spoke about RAPT Therapeutics, Inc. ( RAPT ), it was in a Seeking Alpha article entitled " RAPT: CCR4 Inhibition Presses On For Now With Oncology Focus ." With respect to this article, I primarily noted the development of its CCR4 antag...

ROCH - Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot

2026-01-16 13:31:18 ET The last time I spoke about Shattuck Labs ( STTK ) it was in a prior Seeking Alpha article entitled " Shattuck Labs: Positive Blood Cancer Data Leads To Mid-2024 Catalyst ". With respect to this article, I mentioned that the company had released so...

Next 10